Chonluten: research, legal status and who sells it
This page is information, not medical advice. Chonluten is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Also known as
- Glu-Asp-Gly, EDG peptide
- Category
- Synthetic tripeptide (Khavinson peptide bioregulator)
- Evidence level
- Preclinical (lab and animal studies)
- Price range
- $2.50/mg to $3.10/mg, median $2.88/mg across 9 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | No FDA-approved drug contains chonluten [1]. |
| United Kingdom | No UK-licensed medicine containing chonluten appears in the MHRA products database [2]. |
| European Union | No medicine containing chonluten is authorized in the EU, according to EMA's central and Article 57 product data [3][4]. |
| Canada | No product containing chonluten appears in Health Canada's Drug Product Database [5]. |
| Australia | Chonluten is not named in Australia's Poisons Standard (October 2026) [6]. |
| Sport (WADA) | Not named on the 2026 Prohibited List; its section S0 bans any pharmacological substance with no current approval for human therapeutic use [7]. |
We haven't published a full overview of Chonluten yet. The legal status table and live prices on this page are current.
Chonluten prices: cheapest listings
The five lowest $/mg listings out of 9. See all Chonluten prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Peptide Plugs | 57 | 20 mg | $50 | $2.50/mg | View | ||
| Modern Aminos | 77 | 20 mg | $54 | $2.70/mg | View | ||
| Pure Lab Peptides | 82 | 20 mg | $55 | $2.75/mg | View | ||
| Eros Peptides | 87 | 20 mg | $56 | $2.80/mg | View | ||
| Swiss Chems FDA warning letter, Dec 2024 | 72 | 20 mg | $59 | $2.95/mg | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 15, 2026
- MHRA Products: licensed-medicine search for "chonluten". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 15, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 15, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 15, 2026
- Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. International Journal of Molecular Sciences (2022). Accessed Oct 15, 2026
- Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line. International Journal of Molecular Sciences (2022). Accessed Oct 15, 2026